Equity Research, Broker Reports, and media content on Allergy Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics. We currently have 194 research reports from 8 professional analysts.

Open
11.4p
Range Today
11.0/11.4p
52 Week
8.20/15.5p
Daily Volume
248.3k
# Shares
636.2m
Daily Liquidity
(0.04%)
Pension Liability
£9.52m
Enterprise Value
£56.7m
Market Cap
£71.6m
Latest PE (hist)
23.36
Div Yield
Date Source Announcement
16Jan20 12:25 RNS Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS Half Year Trading Update & Notice of Results
02Dec19 09:57 RNS Holdings in Company
29Nov19 10:34 RNS Holdings in Company
26Nov19 07:00 RNS Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 RNS Result of Annual General Meeting
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics

  • Providers covering

    Allergy Therapeutics